Your session is about to expire
← Back to Search
Behavioural Intervention
Cognitive Rehabilitation for Long COVID Brain Fog
N/A
Recruiting
Led By Gitendra Uswatte, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Mild or greater cognitive impairment
Moderate or greater brain fog
Must not have
Cognitive impairment due to developmental disability, psychiatric disorder, or substance abuse, TBI or progressive brain disease
Stroke prior to the onset of COVID
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from day 30 to day 60, i.e., from pre- to post-treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare two different cognitive rehabilitation approaches for adults with long COVID who have mild to moderate cognitive impairment. One approach focuses on training how quickly individuals process information through web-based computer games and in-l
Who is the study for?
Adults with long COVID experiencing mild to moderate cognitive issues, such as brain fog and trouble with daily activities. They must be over 3 months post-COVID, able to travel to the lab, mentally and physically fit enough for participation, have good vision and hearing, follow instructions well, and speak English. Excluded are those with a history of stroke before COVID-19 or current substance abuse.
What is being tested?
The trial compares two cognitive rehabilitation methods: Constraint-Induced Cognitive Therapy (CICT) focuses on processing speed training and practical tasks including work-related ones; Brain Fitness Training (BFT) emphasizes reaction time training along with lifestyle habits like relaxation. Both use non-invasive vagus nerve stimulation (taVNS) and may include vocational rehab for eligible participants.
What are the potential side effects?
Potential side effects mainly relate to taVNS which could cause discomfort at the stimulation site or other unknown reactions due to its nature as a relatively new treatment method.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I experience some difficulty with my memory or thinking.
Select...
I experience significant confusion or difficulty thinking.
Select...
I can see and hear well enough for daily activities.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have cognitive issues due to a developmental disability, mental health condition, substance abuse, brain injury, or progressive brain disease.
Select...
I had a stroke before getting COVID.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from day 30 to day 60, i.e., from pre- to post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from day 30 to day 60, i.e., from pre- to post-treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Canadian Occupational Performance Measure (COPM)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: CICT + VRExperimental Treatment7 Interventions
Constraint-Induced Cognitive Therapy plus Vocational Rehabilitation uses in-lab training on everyday activities with important cognitive components and procedures designed to transfer improvements from the treatment setting to every day life. This will be combined with computer-based processing speed training and non-invasive vagus nerve stimulation. This group will also receive vocational rehabilitation from the Alabama Department of Rehabilitation Services, such as career counseling and building important career skills.
Group II: CICTExperimental Treatment5 Interventions
Constraint-Induced Cognitive Therapy uses in-lab training on everyday activities with important cognitive components and procedures designed to transfer improvements from the treatment setting to every day life. This will be combined with computer-based processing speed training and non-invasive vagus nerve stimulation.
Group III: BFTActive Control5 Interventions
Brain Fitness Training involves in-lab training on relaxation, healthy nutrition, and healthy sleep with procedures designed to promote integration of these lifestyles into everyday life. This will be combined with computer-based reaction time training and non-invasive vagus nerve stimulation.
Group IV: BFT + VRActive Control6 Interventions
Brain Fitness Training plus Vocational Rehabilitation involves in-lab training on relaxation, healthy nutrition, and healthy sleep with procedures designed to promote integration of these lifestyles into everyday life. This will be combined with computer-based reaction time training and non-invasive vagus nerve stimulation. This group will also receive vocational rehabilitation from the Alabama Department of Rehabilitation Services, such as career counseling and building important career skills.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Processing Speed Training
2013
N/A
~70
Peer Mentoring
2018
N/A
~1410
Vocational Rehabilitation
2011
N/A
~1050
Find a Location
Who is running the clinical trial?
Posit ScienceUNKNOWN
1 Previous Clinical Trials
82 Total Patients Enrolled
National Institute on Disability, Independent Living, and Rehabilitation ResearchFED
80 Previous Clinical Trials
10,097 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,655 Previous Clinical Trials
2,444,118 Total Patients Enrolled
Gitendra Uswatte, PhDPrincipal InvestigatorProfessor of Psychology, University of Alabama at Birmingham
4 Previous Clinical Trials
131 Total Patients Enrolled